Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;212(2):125-131.
doi: 10.1007/s00430-022-00734-9. Epub 2022 Apr 2.

Interferon antagonists encoded by SARS-CoV-2 at a glance

Affiliations
Review

Interferon antagonists encoded by SARS-CoV-2 at a glance

Jung-Hyun Lee et al. Med Microbiol Immunol. 2023 Apr.

Abstract

The innate immune system is a powerful barrier against invading pathogens. Interferons (IFNs) are a major part of the cytokine-mediated anti-viral innate immune response. After recognition of a pathogen by immune sensors, signaling cascades are activated that culminate in the release of IFNs. These activate cells in an autocrine or paracrine fashion eventually setting cells in an anti-viral state via upregulation of hundreds of interferon-stimulated genes (ISGs). To evade the anti-viral effect of the IFN system, successful viruses like the pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolved strategies to counteract both IFN induction and signaling. In fact, more than half of the about 30 proteins encoded by SARS-CoV-2 target the IFN system at multiple levels to escape IFN-mediated restriction. Here, we review recent insights into the molecular mechanisms used by SARS-CoV-2 proteins to suppress IFN production and the establishment of an anti-viral state.

Keywords: COVID-19; Immune evasion; Innate immunity; Interferon; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interests.

Figures

Fig. 1
Fig. 1
Counteraction of the IFN system by SARS-CoV-2 proteins. Schematic depiction of the antagonism of the interferon (IFN) system by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins. Incoming or replicating virus is recognized by Toll-like receptors (TLRs) or RIG-I-like receptors (RLRs) which eventually activates interferon regulatory factor 3 (IRF3) either through TANK binding kinase protein 1 (TBK1) or via mitochondrial antiviral-signaling protein (MAVS). Activated IRF3 dimerizes and translocates to the nucleus, where it induces the production of IFNs. IFNs bind to their respective receptors (e.g., interferon alpha and beta receptor subunit 1, IFNAR) to induce janus kinase (JAK) and tyrosine kinase (TYK) mediated activation of signal transducer and activator of transcription (STATs). Activated STAT complexes (ISGF3) translocate to the nucleus, where they induce transcription of interferon-stimulated genes (ISGs). Induction of ISGs sets the cell in an antiviral state that restricts infection and replication of the virus. SARS-CoV-2 interferes with signal transduction at multiple levels, as indicated by red highlights. Nsp non-structural protein, N nucleocapsid protein, M matrix protein, ORF open reading frame

Comment in

References

    1. Janeway CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197–216. doi: 10.1146/annurev.immunol.20.083001.084359. - DOI - PubMed
    1. Zheng M, Karki R, Williams EP, et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol. 2021;22:829–838. doi: 10.1038/s41590-021-00937-x. - DOI - PMC - PubMed
    1. Tripathi U, Nchioua R, Prata LGPL et al (2021) SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3. Aging 13:21838–21854. 10.18632/aging.203560 - PMC - PubMed
    1. Kell AM, Gale M. RIG-I in RNA virus recognition. Virology. 2015;479–480:110–121. doi: 10.1016/j.virol.2015.02.017. - DOI - PMC - PubMed
    1. Aboudounya MM, Holt MR, Heads RJ (2021) SARS-CoV-2 Spike S1 glycoprotein is a TLR4 agonist, upregulates ACE2 expression and induces pro-inflammatory M1 macrophage polarisation. 2021.08.11.455921

LinkOut - more resources